您的位置：网站名称 → 研发专利新闻 → 正文
内容搜索
热门内容
• USPTO issues notice of
• USPTO issues patent to
• Israel grants patent t
• Shire files lawsuit ag
• US District Court rule
• USPTO rejects Biotage'
• U.S. District Court ru
• USPTO issues Notice of
• Medical industry veter
• EPO Board of Appeal re
• U.S. District Court gr
• Acorda receives patent
推荐内容
• MSF letter criticizes
• EPO grants patent to M
• Pro-Pharmaceuticals re
• USPTO grants Cortex pa
• NovaSterilis novel vac
• USPTO issues patent to
• WSU researcher develop
• Watson Laboratories se
• POZEN, AstraZeneca fil
• Salix Pharmaceuticals
• Acorda receives patent
• U.S. District Court gr
最新内容
• MSF letter criticizes
• EPO grants patent to M
• USPTO grants Cortex pa
• NovaSterilis novel vac
• Pro-Pharmaceuticals re
• POZEN, AstraZeneca fil
• USPTO issues patent to
• WSU researcher develop
• Watson Laboratories se
• Salix Pharmaceuticals
• Acorda receives patent
• U.S. District Court gr
反馈意见和建议

Global settlement agreement reached in Tuschl patents litigation
 添加时间:2011-04-07 原文发表:2011-03-16 人气:2

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced the signing of a global settlement agreement among Alnylam, Max Planck Society ( Max Planck ), the Whitehead Institute for...

查看所有的文章内容需要 VIP会员权限 查看


 
点这里复制本页地址发送给您QQ/MSN上的好友

相关文章
• Argentum responds to recent decision in
• European Patent Office grants ProtAffin
• US District Court rules in favor of Wats
• Israel grants patent to Kamada's Transfe
• HPK receives Reissue Patent for digital
• USPTO rejects Biotage's re-examination a
• GenSpera strengthens intellectual proper
• USPTO grants patent to HistoRx methods f
• BDSI's BEMA drug delivery technology rec
• POZEN files motion for Treximet patent l
• PRWP receives two new patents for Galect
• NephRx receives new U.S. patent for NX00
• USPTO grants patent to ULURU's Altrazeal
• NephRx receives new U.S. patent for NX00

相关评论

本文章所属分类：首页 → 研发专利新闻